Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Vitreoretinal Diseases and Surgery
In what scenarios do you consider using an amniotic membrane graft for macular hole closure?
Related Questions
When should surgical resection be considered for vasoproliferative tumors?
How do you incorporate intravitreal methotrexate injections into the management of traumatic retinal detachment repairs?
How do you determine whether to switch to a different anti-VEGF agent or to Ozurdex after a patient with diabetic macular edema fails a series of Avastin?
In your experience, what factors prompt you to switch a patient with diabetic macular edema to Eylea HD?
What clinical or OCT-based parameters guide your decision to perform an ERM peel in patients with DME and concurrent ERM?
When should delayed removal of an intraocular foreign body be considered?
In clinical practice, how can AMD imaging biomarkers guide risk stratification and shape discussions with patients regarding prognosis and monitoring?
For patients with nAMD who are developing GA in the same eye, do you consider adding anti-complement therapy?
In patients with retinitis pigmentosa–associated cystoid macular edema that is refractory to medical management, does pars plana vitrectomy have a therapeutic role?
What factors guide the choice between early versus delayed vitrectomy after an open globe injury?
